Ajoolabady A et al. (2023) Endoplasmic reticulum stress in liver diseases 77(2):619-639
Akinyemi AO et al (2023) Unveiling the dark side of glucose-regulated protein 78 (GRP78) in cancers and other human pathology: a systematic review. Mol Med 29(1):112
Article PubMed PubMed Central Google Scholar
Alduais Y et al. (2023) Non-small cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment 102(8):e32899
Arab A et al (2017) Potential circulating miRNA signature for early detection of NSCLC. Cancer Genet 216–217:150–158
Ardic S et al (2019) The value of endoplasmic reticulum stress markers (GRP78 and CHOP) in the diagnosis of acute mesenteric ischemia. Am J Emerg Med 37(4):596–602
Bai Y et al (2023) Research progress on the GRP78 gene in the diagnosis, treatment and immunity of cervical cancer. Eur J Med Res 28(1):447
Article PubMed PubMed Central Google Scholar
Bailly C, Waring MJ (2019) Pharmacological effectors of GRP78 chaperone in cancers. Biochem Pharmacol 163:269–278
Basu A, Krishnamurthy S (2010) Cellular responses to Cisplatin-induced DNA damage. J Nucleic Acids 2010:201367
Article PubMed PubMed Central Google Scholar
Celik C et al (2023) Endoplasmic reticulum stress and lipids in health and diseases. Prog Lipid Res 89:101198
Chen W et al (2016) MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC. J Exp Clin Cancer Res 35:76
Article PubMed PubMed Central Google Scholar
Coughlin JM et al (2020) Understanding barriers to lung cancer screening in primary care. J Thorac Dis 12(5):2536–2544
Article PubMed PubMed Central Google Scholar
Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364–378
Article PubMed PubMed Central Google Scholar
Dauer P et al (2018) GRP78-mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells. Mol Oncol 12(9):1498–1512
Article PubMed PubMed Central Google Scholar
English AR, Zurek N, Voeltz GK (2009) Peripheral ER structure and function. Curr Opin Cell Biol 21(4):596–602
Article PubMed PubMed Central Google Scholar
Guo W et al (2023) Recent advances in small molecule and peptide inhibitors of glucose-regulated protein 78 for cancer therapy. Eur J Med Chem 261:115792
Han J et al. (2024) SLC9A2, suppressing by the transcription suppressor ETS1, restrains growth and invasion of osteosarcoma via inhibition of aerobic glycolysis. 39(1):238–251
Hetz C, Zhang K (2020) Mechanisms, regulation and functions of the unfolded protein response. 21(8):421-438
Ibrahim IM, Abdelmalek DH, Elfiky AA (2019) GRP78: A cell’s response to stress. Life Sci 226:156–163
Article PubMed PubMed Central Google Scholar
Ishteyaque S et al (2023) CYP2E1 triggered GRP78/ATF6/CHOP signaling axis inhibit apoptosis and promotes progression of hepatocellular carcinoma. Arch Biochem Biophys 745:109701
Ji S et al. (2023) Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases. 8(1):116
Jin T et al. (2021) iPLA(2)β Contributes to ER stress-induced apoptosis during myocardial ischemia/reperfusion injury. 10(6)
Lei Y et al (2024) Molecular mechanism of ATF6 in unfolded protein response and its role in disease. Heliyon 10(5):e25937
Article PubMed PubMed Central Google Scholar
Li J, Lee AS (2006) Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med 6(1):45–54
Liu Y et al (2024) ETS1-mediated Regulation of SOAT1 Enhances the Malignant Phenotype of Oral Squamous Cell Carcinoma and Induces Tumor-associated Macrophages M2-like Polarization. Int J Biol Sci 20(9):3372–3392
Article PubMed PubMed Central Google Scholar
Liu S et al. (2024) Targeting PAK4 reverses cisplatin resistance in NSCLC by modulating ER stress 10(1): 36
Luchtel RA (2024) ETS1 function in leukemia and lymphoma. Adv Exp Med Biol 1459:359–378
Mihailidou C et al (2015) Improvement of chemotherapeutic drug efficacy by endoplasmic reticulum stress. Endocr Relat Cancer 22(2):229–238
Millien G et al. (2018) ETS1 regulates Twist1 transcription in a Kras(G12D)/Lkb1(-/-) metastatic lung tumor model of non-small cell lung cancer. 35(3):149–165
Mu W et al (2024) Endoplasmic reticulum stress and quality control in relation to cisplatin resistance in tumor cells. Front Pharmacol 15:1419468
Article PubMed PubMed Central Google Scholar
Qu WQ, Liu L, Yu Z (2015) Clinical value of microRNA-23a upregulation in non-small cell lung cancer. Int J Clin Exp Med 8(8):13598–13603
PubMed PubMed Central Google Scholar
Ranganathan AC et al (2006) Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res 66(3):1702–1711
Article PubMed PubMed Central Google Scholar
Roller C, Maddalo D (2013) The molecular chaperone GRP78/BiP in the development of chemoresistance: mechanism and possible treatment. Front Pharmacol 4:10
Article PubMed PubMed Central Google Scholar
Siegel RL, Miller KD (2020) Cancer statistics. 2020.70(1):7–30
Tchounwou PB et al (2021) Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy. J Exp Pharmacol 13:303–328
Article PubMed PubMed Central Google Scholar
Tian G, Li J, Zhou L (2023) Ginsenoside Rg1 regulates autophagy and endoplasmic reticulum stress via the AMPK/mTOR and PERK/ATF4/CHOP pathways to alleviate alcohol‑induced myocardial injury. Int J Mol Med 52(1)
Wang Y et al (2023) ETS transcription factors: Multifaceted players from cancer progression to tumor immunity. Biochim Biophys Acta Rev Cancer 1878(3):188872
Wu D et al. (2023) Research progress on endoplasmic reticulum homeostasis in kidney diseases 14(7):473
Xia S et al. (2021) GRP78 in lung cancer 19(1):118
Xu M et al (2019) Lysophosphatidic acid induces integrin β6 expression in human oral squamous cell carcinomas cells via LPAR1 coupling to Gα(i) and downstream SMAD3 and ETS-1 activation. Cell Signal 60:81–90
Xu S et al (2023a) Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2. Front Immunol 14:1155182
Article PubMed PubMed Central Google Scholar
Xu J et al (2023b) Disturbance of neuron-microglia crosstalk mediated by GRP78 in Neuropsychiatric systemic lupus erythematosus mice. J Neuroinflammation 20(1):150
Article PubMed PubMed Central Google Scholar
Xu S et al (2024a) Multi-omics identification of a signature based on malignant cell-associated ligand-receptor genes for lung adenocarcinoma. BMC Cancer 24(1):1138
Article PubMed PubMed Central Google Scholar
Xu S et al (2024b) Causal association between immune cells and lung cancer risk: a two-sample bidirectional Mendelian randomization analysis. Front Immunol 15:1433299
Article PubMed PubMed Central Google Scholar
Xu S et al (2024c) Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response. BMC Cancer 24(1):1064
Article PubMed PubMed Central Google Scholar
Xu S, Lu Z (2024) The role of LMNB2 as a diagnostic and prognostic biomarker in lung adenocarcinoma. Asian J Surg
Yang S et al (2016) microRNA-361 targets Wilms’ tumor 1 to inhibit the growth, migration and invasion of non-small-cell lung cancer cells. Mol Med Rep 14(6):5415–5421
留言 (0)